Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

287
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
287
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

83
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
83
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

535
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
535
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

100
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
100
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

1.4K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.4K
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

93
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
93

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microwave coprocessing of modafinil with Gelucire<sup>®</sup>: Thermal and compression characteristics.

ADMET & DMPK·2025
Same author

Modafinil-excipient compatibility study using differential scanning calorimetry.

Journal of advanced pharmaceutical technology & research·2023
Same author

Investigating Variation in Compressional Behavior of a Ternary Mixture from a Plastic, Elastic and Brittle Fracture Perspective in the Context of Optimum Composition of a Pharmaceutical Blend.

Polymers·2023
Same author

Retraction notice to "Evaluation of the surface chemistry and drug-polymer interaction of semi-crystalline micro-particles for the development of controlled release formulations" [Mater. Sci. Eng. C (2017) 559-567].

Materials science & engineering. C, Materials for biological applications·2021
Same author

Elucidation of the Controlled-Release Behavior of Metoprolol Succinate from Directly Compressed Xanthan Gum/Chitosan Polymers: Computational and Experimental Studies.

ACS biomaterials science & engineering·2021
Same author

Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.

Marine drugs·2020

Related Experiment Video

Updated: Nov 30, 2025

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
05:26

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

Published on: April 13, 2022

3.7K

Influence of Chitin Source and Polymorphism on Powder Compression and Compaction: Application in Drug Delivery.

Linda Al-Hmoud1, Deeb Abu Fara1, Iyad Rashid2

  • 1Chemical Engineering Department, School of Engineering, University of Jordan, Amman 11942, Jordan.

Molecules (Basel, Switzerland)
|November 17, 2020
PubMed
Summary

This study compares chitin from crabs, shrimp, and squid, finding both alpha and beta polymorphic forms are suitable for fast-dissolving tablets. Chitin source and polymorphic form significantly impact compaction properties.

Keywords:
chitinchitin characterizationchitin sourcescompression analysiscrushing strengthdisintegrationdissolutionpolymorphs

More Related Videos

Preparation of Expanded Chitin Foams and their Use in the Removal of Aqueous Copper
06:36

Preparation of Expanded Chitin Foams and their Use in the Removal of Aqueous Copper

Published on: February 27, 2021

4.0K
Frugal Imaging Technique of Capillary Flow Through Three-Dimensional Polymeric Printing Powders
06:01

Frugal Imaging Technique of Capillary Flow Through Three-Dimensional Polymeric Printing Powders

Published on: October 4, 2022

1.5K

Related Experiment Videos

Last Updated: Nov 30, 2025

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
05:26

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications

Published on: April 13, 2022

3.7K
Preparation of Expanded Chitin Foams and their Use in the Removal of Aqueous Copper
06:36

Preparation of Expanded Chitin Foams and their Use in the Removal of Aqueous Copper

Published on: February 27, 2021

4.0K
Frugal Imaging Technique of Capillary Flow Through Three-Dimensional Polymeric Printing Powders
06:01

Frugal Imaging Technique of Capillary Flow Through Three-Dimensional Polymeric Printing Powders

Published on: October 4, 2022

1.5K

Area of Science:

  • Biomaterials Science
  • Pharmaceutical Technology
  • Marine Biotechnology

Background:

  • Chitin, a biopolymer from crustacean and mollusk exoskeletons, is widely used in the seafood industry.
  • Understanding chitin's physical properties is crucial for its pharmaceutical applications.
  • Polymorphism in chitin influences its material characteristics and processing behavior.

Purpose of the Study:

  • To compare the compaction properties of chitin extracted from crabs, shrimps, and squids.
  • To investigate the influence of chitin's polymorphic forms (alpha and beta) on its compression and compaction behavior.
  • To evaluate the suitability of chitin for pharmaceutical applications, specifically fast-dissolving tablets.

Main Methods:

  • Chitin extraction from crabs, shrimps, and squids.
  • Characterization of chitin polymorphs using Fourier-transform infrared spectroscopy (FTIR), X-ray powder diffraction, and scanning electron microscopy (SEM).
  • Analysis of powder densities (true, bulk, tapped) and compaction properties using Heckle and Kawakita analyses.

Main Results:

  • Crab and shrimp chitin exhibited the alpha-polymorphic form, while squid chitin displayed the beta-polymorphic form.
  • The beta form showed smaller pore diameter and volume compared to the alpha form.
  • Both chitin polymorphs demonstrated poor flowability but good compaction properties, yielding high crushing strength and rapid dissolution.
  • Chitin compacts, when granulated with model drugs, met compendial dissolution requirements.

Conclusions:

  • The source of chitin extraction is as critical as its polymorphic form for successful compression and compaction.
  • Chitin's excellent compaction and dissolution characteristics make it a promising excipient for fast-dissolving oral dosage forms.
  • Further research into chitin processing can optimize its use in pharmaceutical formulations.